GVCCX
Price
$6.96
Change
-$0.11 (-1.56%)
Updated
Feb 21 closing price
Net Assets
217.17M
VMVAX
Price
$85.40
Change
-$0.97 (-1.12%)
Updated
Feb 21 closing price
Net Assets
30.89B
Ad is loading...

GVCCX vs VMVAX

Header iconGVCCX vs VMVAX Comparison
Open Charts GVCCX vs VMVAXBanner chart's image
Gabelli Value 25 C
Price$6.96
Change-$0.11 (-1.56%)
VolumeN/A
Net Assets217.17M
Vanguard Mid-Cap Value Index Admiral
Price$85.40
Change-$0.97 (-1.12%)
VolumeN/A
Net Assets30.89B
GVCCX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GVCCX vs. VMVAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVCCX is a Hold and VMVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. GVCCX (217M). VMVAX pays higher dividends than GVCCX: VMVAX (2.14) vs GVCCX (0.00). GVCCX was incepted earlier than VMVAX: GVCCX (25 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. GVCCX (6.00). GVCCX has a lower initial minimum investment than VMVAX: GVCCX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 12.44 vs. GVCCX (8.92). VMVAX return over 5 years is better than : 38.46 vs. GVCCX (-30.41).
GVCCXVMVAXGVCCX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years13 years-
Gain YTD6.4221.921334%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets217M30.9B1%
Annual Yield % from dividends0.002.14-
Returns for 1 year8.9212.4472%
Returns for 3 years-19.2615.34-126%
Returns for 5 years-30.4138.46-79%
Returns for 10 years-56.1681.26-69%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDI9.96-0.02
-0.20%
DoubleDown Interactive Co Ltd
MANU14.46-0.15
-1.03%
Manchester United PLC
SRPT106.28-2.13
-1.96%
Sarepta Therapeutics
FTK8.22-0.20
-2.38%
Flotek Industries
ARTL1.16-0.04
-3.33%
Artelo Biosciences